Clinical Trials in Rheumatoid Arthritis and Osteoarthritis
Published on 2. May 2011
Book
Paperback/Softback
336 pages
978-1-84996-014-4 (ISBN)
More details
Edition
Edition. ed.
Language
English
Place of publication
England
United Kingdom
Target group
Professional and scholarly
Illustrations
30 black & white illustrations, 24 colour illustrations, 17 black & white halftones, 12 colour illustrations, 13 black & white line drawings, 12 colour line drawings
Dimensions
Height: 235 mm
Width: 155 mm
ISBN-13
978-1-84996-014-4 (9781849960144)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
David M. Reid | Colin G. Miller
Clinical Trials in Rheumatoid Arthritis and Osteoarthritis
Book
05/2008
Springer
€106.99
Shipment within 15-20 days
Content
Introduction.- Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis.- Current and Some Future Biological Therapies used in Inflammatory Arthritis.- Study Design and Endpoints for Rheumatoid Arthritis Trials.- Study design and endpoints in AS clinical trials.- Trial design and Outcomes in Osteoarthritis.- Ethical Considerations.- Organization of the Clinical Trial by the Sponsor.- The Organisation of the Trial at the Investigator Site.- The Role of the Imaging Core Lab in Rheumatoid Arthritis and Osteoarthritis Clinical Trials.- Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations.- Data Analysis and Presentation: Writing a Paper for Publication.- Radiographic Imaging Endpoints in Rheumatoid Arthritis Trials.- Radiography in Clinical Trials Investigating Osteoarthritis.- Use of Quantitative Magnetic Resonance Imaging (qMRI) in the Cross-sectional and Longitudinal Evaluation of Structural Changes in Knee Osteoarthritis Patients.- Biochemical Markers as Surrogate Endpoints of Joint Disease.- Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis.- Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis